Page last updated: 2024-11-01

omeprazole and Glomerulonephritis, Lupus

omeprazole has been researched along with Glomerulonephritis, Lupus in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Helsby, N1
Goldthorpe, M1
Gow, P1
de Zoysa, J1

Other Studies

1 other study available for omeprazole and Glomerulonephritis, Lupus

ArticleYear
Is the prevalence of CYP2C19 genetic variants different in Pacific people than in New Zealand Europeans?
    The New Zealand medical journal, 2010, May-28, Volume: 123, Issue:1315

    Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; DNA; Enzyme Inhibitors; Europe; Ge

2010